GlassScriptPhysician profile
Ashley R Prichard
NPI 1851650154
$10,818.07
in general payments reported to CMS, 2019-2025
35 companies · $2,101 in 2025
The $2,101 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,607 · 2022: $1,271 · 2023: $2,086 · 2024: $1,752 · 2025: $2,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,939.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,718.69 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Nevro Corp. | $1,050.72 | 2021-2024 | Senza |
| Abbvie INC. | $575.39 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $469.78 | 2021-2025 | Belbuca, Xtampza |
| Amgen INC. | $371.46 | 2021-2023 | Evenity, Prolia |
| Globus Medical, INC. | $364.95 | 2025 | Senza, Vyrsa V1 |
| Lundbeck LLC | $217.32 | 2022-2025 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.00 | 2022-2025 | Relistor |
| Pfizer INC. | $207.39 | 2023-2025 | |
| Medtronic, INC. | $168.85 | 2021-2023 | Intellis Adaptivestim |
| Scilex Pharmaceuticals INC. | $163.09 | 2021-2023 | Ztlido |
| Vertos Medical, INC. | $132.75 | 2024 | Mild Device Kit |
| Protega Pharmaceutials INC | $132.49 | 2022-2023 | Roxybond |
| Stimwave Technologies Incorporated | $122.50 | 2022 | |
| Ibsa Pharma INC. | $99.81 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $95.58 | 2024-2025 | |
| Redhill Biopharma INC. | $77.28 | 2021-2022 | |
| Spr Therapeutics, INC | $73.87 | 2022-2025 | Sprint Pns System |
| Ipsen Biopharmaceuticals, INC | $63.50 | 2024-2025 | Dysport |
| Painteq LLC | $51.22 | 2023-2024 | Painteq |
| Saluda Medical Americas, INC. | $50.76 | 2024-2025 | Evoke |
| Azurity Pharmaceuticals, INC. | $49.11 | 2023-2025 | Horizant, Horizant |
| Teva Pharmaceuticals USA, INC. | $44.83 | 2022-2023 | Austedo Xr |
| Nalu Medical, INC. | $41.19 | 2024 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $37.25 | 2021 | |
| Grt US Holding, INC. | $33.01 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $32.94 | 2023 | Lyvispah |
| Eisai INC. | $27.71 | 2021 | |
| Hikma Pharmaceuticals USA | $25.95 | 2021 | |
| Impel Pharmaceuticals LLC | $23.45 | 2025 | Trudhesa |
| Lilly USA, LLC | $21.39 | 2022 | |
| Curonix LLC | $17.50 | 2022 | |
| Impel Pharmaceuticals INC. | $16.10 | 2023 | Trudhesa |
| Radius Health, INC. | $14.23 | 2024 | Tymlos |
| Arbor Pharmaceuticals, INC. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Prichard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.